On September 4, Apple fell 3.05% in regular trading, trading at $317.955 per share, with turnover of $4.181 billion. Multiple negative catalysts converged to pressure the stock.
On the production front, sources revealed that Apple's foldable iPhone daily output stood at only \"a few hundred units\" as of late August, far short of the tens of thousands per day needed to meet its full-year target of 8 to 10 million units. Apple imposed an additional verification process in August to ensure mass-production feasibility, delaying commercial production by several weeks. Industry executives warned that if the ramp-up does not accelerate, the device could face severe channel inventory shortages at launch. IDC projected the foldable iPhone's average selling price at $2,550, above prior expectations due to chip shortages and supply chain bottlenecks.
Additionally, Apple canceled development of a foldable MacBook and a mid-size OLED MacBook, narrowing its product roadmap. On the legal front, BASF filed a patent infringement suit against Apple over facial authentication technology used in iPhones and iPads, adding to a $2.7 billion UK class action alleging anti-competitive App Tracking Transparency practices.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments